Advanced HIV Disease Among Males and Females Initiating HIV Care in Rural Ethiopia

Overview

Journal J Int Assoc Provid AIDS Care

Publisher Sage Publications

Specialty Infectious Diseases

Date 2019 May 21

PMID 31104543

Citations 15

Authors

Alan Raymond Lifson

Sale Workneh

Abera Hailemichael

Richard Fleming MacLehose

Keith Joseph Horvath

Rose Hilk

Anne Redmond Sites

Tibebe Shenie

Affiliations

Soon will be listed here.

Abstract

Despite recommendations for rapidly initiating HIV treatment, many persons in sub-Saharan Africa present to care with advanced HIV disease. Baseline survey and clinical data were collected on 1799 adults newly enrolling at 32 district hospitals and local health HIV clinics in rural Ethiopia. Among those with complete HIV disease information, advanced HIV disease (defined as CD4 count <200 cells/mm or World Health Organization [WHO] HIV clinical stage III or IV disease) was present in 66% of males and 56% of females ( P < .001). Males (compared to females) had lower CD4 counts (287 cells/mm versus 345 cells/mm), lower body mass index (19.3 kg/m versus 20.2 kg/m), and more WHO stage III or IV disease (46% versus 37%), ( P < .001). Men reported more chronic diarrhea, fevers, cough, pain, fatigue, and weight loss ( P < .05). Most initiating care in this resource-limited setting had advanced HIV disease. Men had poorer health status, supporting the importance of earlier diagnosis, linkage to care, and initiation of antiretroviral therapy.

Citing Articles

A cross-sectional study evaluating the screening, diagnosis and management of advanced HIV disease at the AIDS support organization service centre in Mbarara City, Southwestern Uganda.

Tukamuhebwa P, Gemmell I BMC Infect Dis. 2025; 25(1):254.

PMID: 39988695 PMC: 11849361. DOI: 10.1186/s12879-025-10682-3.

Persistent advanced HIV disease in rural KwaZulu-Natal, South Africa: Trends, characteristics, and the urgent need for targeted interventions.

Kitenge M, Fatti G, Eshun-Wilson I, Nyasulu P PLoS One. 2025; 20(2):e0317674.

PMID: 39965033 PMC: 11835316. DOI: 10.1371/journal.pone.0317674.

Global prevalence of advanced HIV disease in healthcare settings: a rapid review.

Ford N, Kassanjee R, Stelzle D, Jarvis J, Sued O, Perrin G J Int AIDS Soc. 2025; 28(2):e26415.

PMID: 39915008 PMC: 11802239. DOI: 10.1002/jia2.26415.

Prevalence, Predictors, and Outcomes of HIV Care in HIV-Positive Clients Entering HIV Care With Advanced HIV Disease in Sub-Saharan Africa 2010-2022: Systematic Review and Meta-Analysis.

Haumba S, Arora S, Williams V, Maseko T, Mafukidze A, Ojoo S Health Sci Rep. 2024; 7(12):e70285.

PMID: 39720238 PMC: 11667100. DOI: 10.1002/hsr2.70285.

Advanced HIV disease and its predictors among newly diagnosed PLHIV in the Gedeo zone, southern Ethiopia.

Lerango T, Markos T, Yehualeshet D, Kefyalew E, Lerango S PLoS One. 2024; 19(9):e0310373.

PMID: 39269935 PMC: 11398689. DOI: 10.1371/journal.pone.0310373.

References

Nash D, Tymejczyk O, Gadisa T, Kulkarni S, Hoffman S, Yigzaw M . Factors associated with initiation of antiretroviral therapy in the advanced stages of HIV infection in six Ethiopian HIV clinics, 2012 to 2013. J Int AIDS Soc. 2016; 19(1):20637. PMC: 4845592. DOI: 10.7448/IAS.19.1.20637. View

Okulicz J, Le T, Agan B, Camargo J, Landrum M, Wright E . Influence of the timing of antiretroviral therapy on the potential for normalization of immune status in human immunodeficiency virus 1-infected individuals. JAMA Intern Med. 2014; 175(1):88-99. PMC: 4286496. DOI: 10.1001/jamainternmed.2014.4010. View

Geng E, Bwana M, Muyindike W, Glidden D, Bangsberg D, Neilands T . Failure to initiate antiretroviral therapy, loss to follow-up and mortality among HIV-infected patients during the pre-ART period in Uganda. J Acquir Immune Defic Syndr. 2013; 63(2):e64-71. PMC: 3654002. DOI: 10.1097/QAI.0b013e31828af5a6. View

Spiegelman D, Hertzmark E . Easy SAS calculations for risk or prevalence ratios and differences. Am J Epidemiol. 2005; 162(3):199-200. DOI: 10.1093/aje/kwi188. View

Carmona S, Bor J, Nattey C, Maughan-Brown B, Maskew M, Fox M . Persistent High Burden of Advanced HIV Disease Among Patients Seeking Care in South Africa's National HIV Program: Data From a Nationwide Laboratory Cohort. Clin Infect Dis. 2018; 66(suppl_2):S111-S117. PMC: 5850436. DOI: 10.1093/cid/ciy045. View

Osler M, Hilderbrand K, Goemaere E, Ford N, Smith M, Meintjes G . The Continuing Burden of Advanced HIV Disease Over 10 Years of Increasing Antiretroviral Therapy Coverage in South Africa. Clin Infect Dis. 2018; 66(suppl_2):S118-S125. PMC: 5850025. DOI: 10.1093/cid/cix1140. View

MacKellar D, Williams D, Bhembe B, Dlamini M, Byrd J, Dube L . Peer-Delivered Linkage Case Management and Same-Day ART Initiation for Men and Young Persons with HIV Infection - Eswatini, 2015-2017. MMWR Morb Mortal Wkly Rep. 2018; 67(23):663-667. PMC: 6002033. DOI: 10.15585/mmwr.mm6723a3. View

Lundgren J, Babiker A, Gordin F, Emery S, Grund B, Sharma S . Initiation of Antiretroviral Therapy in Early Asymptomatic HIV Infection. N Engl J Med. 2015; 373(9):795-807. PMC: 4569751. DOI: 10.1056/NEJMoa1506816. View

Jain V, Hartogensis W, Bacchetti P, Hunt P, Hatano H, Sinclair E . Antiretroviral therapy initiated within 6 months of HIV infection is associated with lower T-cell activation and smaller HIV reservoir size. J Infect Dis. 2013; 208(8):1202-11. PMC: 3778965. DOI: 10.1093/infdis/jit311. View

10.

Auld A, Shiraishi R, Mbofana F, Couto A, Fetogang E, El-Halabi S . Lower Levels of Antiretroviral Therapy Enrollment Among Men with HIV Compared with Women - 12 Countries, 2002-2013. MMWR Morb Mortal Wkly Rep. 2015; 64(46):1281-6. DOI: 10.15585/mmwr.mm6446a2. View

11.

Baker J, Sharma S, Grund B, Rupert A, Metcalf J, Schechter M . Systemic Inflammation, Coagulation, and Clinical Risk in the START Trial. Open Forum Infect Dis. 2018; 4(4):ofx262. PMC: 5751061. DOI: 10.1093/ofid/ofx262. View

12.

Cohen M, Chen Y, McCauley M, Gamble T, Hosseinipour M, Kumarasamy N . Antiretroviral Therapy for the Prevention of HIV-1 Transmission. N Engl J Med. 2016; 375(9):830-9. PMC: 5049503. DOI: 10.1056/NEJMoa1600693. View

13.

Treves-Kagan S, El Ayadi A, Pettifor A, MacPhail C, Twine R, Maman S . Gender, HIV Testing and Stigma: The Association of HIV Testing Behaviors and Community-Level and Individual-Level Stigma in Rural South Africa Differ for Men and Women. AIDS Behav. 2017; 21(9):2579-2588. PMC: 5498263. DOI: 10.1007/s10461-016-1671-8. View

14.

Siedner M, Ng C, Bassett I, Katz I, Bangsberg D, Tsai A . Trends in CD4 count at presentation to care and treatment initiation in sub-Saharan Africa, 2002-2013: a meta-analysis. Clin Infect Dis. 2014; 60(7):1120-7. PMC: 4366582. DOI: 10.1093/cid/ciu1137. View

15.

Lifson A, Workneh S, Hailemichael A, MacLehose R, Horvath K, Hilk R . A multi-site community randomized trial of community health workers to provide counseling and support for patients newly entering HIV care in rural Ethiopia: study design and baseline implementation. HIV Clin Trials. 2018; 19(3):112-119. PMC: 6082124. DOI: 10.1080/15284336.2018.1461999. View

16.

Nyika H, Mugurungi O, Shambira G, Gombe N, Bangure D, Mungati M . Factors associated with late presentation for HIV/AIDS care in Harare City, Zimbabwe, 2015. BMC Public Health. 2016; 16:369. PMC: 4855488. DOI: 10.1186/s12889-016-3044-7. View

17.

Maheu-Giroux M, Tanser F, Boily M, Pillay D, Joseph S, Barnighausen T . Determinants of time from HIV infection to linkage-to-care in rural KwaZulu-Natal, South Africa. AIDS. 2017; 31(7):1017-1024. PMC: 5859256. DOI: 10.1097/QAD.0000000000001435. View

18.

Cornell M, Schomaker M, Garone D, Giddy J, Hoffmann C, Lessells R . Gender differences in survival among adult patients starting antiretroviral therapy in South Africa: a multicentre cohort study. PLoS Med. 2012; 9(9):e1001304. PMC: 3433409. DOI: 10.1371/journal.pmed.1001304. View

19.

Kojima N, Klausner J . Strategies to Increase Human Immunodeficiency Virus Testing Among Men to Reach UNAIDS 90-90-90 Targets. Clin Infect Dis. 2018; 67(9):1468-1469. PMC: 6186854. DOI: 10.1093/cid/ciy344. View

20.

Lahuerta M, Wu Y, Hoffman S, Elul B, Kulkarni S, Remien R . Advanced HIV disease at entry into HIV care and initiation of antiretroviral therapy during 2006-2011: findings from four sub-saharan African countries. Clin Infect Dis. 2013; 58(3):432-41. PMC: 3890338. DOI: 10.1093/cid/cit724. View